Document:

Exhibit 4.1

 

THIS
PURCHASE WARRANT AND THE SECURITIES DELIVERABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,
AS AMENDED (THE “ACT”), OR APPLICABLE STATE LAW. THIS PURCHASE WARRANT MAY NOT BE OFFERED FOR SALE, SOLD, EXERCISED
OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT, OR PURSUANT TO AN EXEMPTION FROM
REGISTRATION UNDER THE ACT AND APPLICABLE STATE LAW WHICH, IN THE OPINION OF COUNSEL TO THE COMPANY, IS AVAILABLE.

 

COMMON
STOCK PURCHASE WARRANT

 

For
the Purchase of [●] Shares of Common Stock

 

of

 

American
BriVision (Holding) Corporation

 

1.
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [INVESTOR] (“Holder”),
as registered owner of this Purchase Warrant, to American BriVision (Holding) Corporation., a Nevada company (the “Company”),
Holder is entitled, at any time or from time to time from [●], 2020 (the “Commencement Date”), and at
or before 5:00 p.m., Eastern time, [●], 2023, (the “Expiration Date”), but not thereafter, to subscribe
for, purchase and receive, in whole or in part, up to [●] shares of of common stock of the Company, par value $0.001 (the
“Shares”), subject to adjustment as provided in Section 5 hereof. If the Expiration Date is a day on
which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding
day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company
agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $5.00
per Share; provided, however, that upon the occurrence of any of the events specified in Section 4 hereof,
the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon
such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise
price or the adjusted exercise price, depending on the context. Capitalized terms used and not otherwise defined herein shall
have the meanings set forth in that certain Exchange Agreement, dated April 5, 2020, between the Company and the Holder (the “Agreement”)

 

2.
Exercise.

 

2.1.
Exercise Form. In order to exercise this Purchase Warrant, the exercise form attached hereto (“Notice of Exercise”)
must be duly executed and completed and delivered to the Company, together with this Purchase Warrant and payment of the Exercise
Price for the Shares being purchased payable in cash by wire transfer of immediately available funds to an account designated
by the Company or by certified check or official bank check. If the subscription rights represented hereby shall not be exercised
at or before 5:00 p.m., Eastern Time, on the Expiration Date, this Purchase Warrant shall become and be void without further force
or effect, and all rights represented hereby shall cease and expire. Notwithstanding anything herein to the contrary, the Holder
shall not be required to physically surrender this Purchase Warrant to the Company until the Holder has purchased all of the Shares
available hereunder and the Purchase Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant
to the Company for cancellation within three (3) business days of the date the final notice of exercise is delivered to the Company.
Partial exercises of this Purchase Warrant resulting in purchases of a portion of the total number of Shares available hereunder
shall have the effect of lowering the outstanding number of Shares purchasable hereunder in an amount equal to the applicable
number of Shares purchased. The Holder and the Company shall maintain records showing the number of Shares purchased and the date
of such purchases; provided that the records of the Company, absent manifest error, will be conclusive with respect to the number
of Shares purchasable from time to time hereunder.

 

     

     

    

 

2.2.
Mandatory Exercise. If at any time from and after the date hereof, the closing price of the Company’s common stock on the
Trading Market equals or exceeds $9.00 per share (which amount may be adjusted for certain capital events, such as stock splits,
as described herein) for twenty (20) Trading Days during any thirty (30) day period (the “Mandatory Exercise Measuring Period”),
then the Company shall have the right to require the Holder to exercise all or any portion of this Warrant still unexercised for
a cash exercise, as designated in the Mandatory Exercise Notice on the Mandatory Exercise Date (each as defined below) into fully
paid, validly issued and nonassessable shares of Common Stock in accordance with Section 2 hereof at the Exercise Price as of
the Mandatory Exercise Date (as defined below) (a “Mandatory Exercise”). The Company may exercise its right to require
exercise under this Section 2 by delivering within not more than five (5) Trading Days following the end of such Mandatory Exercise
Measuring Period a written notice thereof by electronic mail to the Holder (the “Mandatory Exercise Notice” and the
date that the Holder received such notice is referred to as the “Mandatory Exercise Notice Date”). The Mandatory Exercise
Notice shall be irrevocable. The Mandatory Exercise Notice shall state (I) the Trading Day on which the Mandatory Exercise shall
occur, which shall be the second (2nd) Trading Day following the Mandatory Exercise Notice Date (the “Mandatory Exercise
Date”) and (II) the aggregate number of Warrants which the Company has elected to be subject to such Mandatory Exercise
from the Holder (the “Mandatory Exercise Amount”) pursuant to this Section 2. If the Warrants have not been exercised
by the Mandatory Exercise Date, the Warrants shall be cancelled.

 

2.3.
Mechanics of Exercise

 

2.3.1.
Delivery of Shares upon Exercise. The Company shall use its best efforts to cause the Shares purchased hereunder to be
transmitted by the Company’s transfer agent to the Holder by crediting the account of the Holder’s prime broker with
The Depository Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is then
a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Shares
to or resale of the Shares or (B) this Purchase Warrant is being exercised via cashless exercise, and otherwise by physical delivery
to the address specified by the Holder in the Notice of Exercise by the date that is no later than 11:00 am, Eastern time, on
the third (3rd) business day after the latest of (A) the delivery to the Company of the Notice of Exercise, (B) surrender of this
Purchase Warrant (if required) and (C) payment of the aggregate Exercise Price as set forth above (including by cashless exercise,
if permitted) (such date, the “Share Delivery Date”). The Shares shall be deemed to have been issued, and Holder
or any other person so designated to be named therein shall be deemed to have become a holder of record of such shares for all
purposes, as of the date the Purchase Warrant has been exercised, with payment to the Company of the Exercise Price (or by cashless
exercise, if permitted) and all taxes required to be paid by the Holder, if any, pursuant to Section 2.6.6 prior to the
issuance of such shares, having been paid.

 

2.3.2.
Delivery of New Purchase Warrant upon Exercise. If this Purchase Warrant shall have been exercised in part, the Company
shall, at the request of a Holder and upon surrender of this Purchase Warrant, at the time of delivery of the Shares, deliver
to the Holder a new Purchase Warrant evidencing the rights of the Holder to purchase the unpurchased Shares called for by this
Purchase Warrant, which new Purchase Warrant shall in all other respects be identical with this Purchase Warrant.

 

2.3.3.
Rescission Rights. If the Company fails to cause its transfer agent to transmit to the Holder the Shares pursuant to Section
2.6.1 by the Share Delivery Date, then the Holder will have the right to rescind such exercise.

 

     2

     

    

 

2.3.4.
No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Purchase Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise,
the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such
fraction multiplied by the Exercise Price or round up to the next whole share.

 

2.3.5.
Closing of Books. The Company will not close its shareholder books or records in any manner which prevents the timely exercise
of this Purchase Warrant, pursuant to the terms hereof.

 

2.4.
General Terms.

 

3.
New Purchase Warrants to be Issued.

 

3.1.
Partial Exercise or Transfer. Subject to the restrictions in Section 3 hereof, this Purchase Warrant may be exercised
or assigned in whole or in part. In the event of the exercise or assignment hereof in part only, upon surrender of this Purchase
Warrant for cancellation, together with the duly executed exercise or assignment form and funds sufficient to pay any Exercise
Price and/or transfer tax if exercised pursuant to Section 2.1 hereto, the Company shall cause to be delivered to the Holder
without charge a new Purchase Warrant of like tenor to this Purchase Warrant in the name of the Holder evidencing the right of
the Holder to purchase the number of Shares purchasable hereunder as to which this Purchase Warrant has not been exercised or
assigned.

 

3.2.
Lost Certificate. Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation
of this Purchase Warrant and of reasonably satisfactory indemnification or the posting of a bond, the Company shall execute and
deliver a new Purchase Warrant of like tenor and date. Any such new Purchase Warrant executed and delivered as a result of such
loss, theft, mutilation or destruction shall constitute a substitute contractual obligation on the part of the Company.

 

4.
Adjustments.

 

4.1.
Adjustments to Exercise Price and Number of Securities. The Exercise Price and the number of Shares underlying the Purchase
Warrant shall be subject to adjustment from time to time as hereinafter set forth:

 

4.1.1.
Share Dividends; Split Ups. If, after the date hereof, and subject to the provisions of Section 5.3 below, the number
of outstanding Shares is increased by a share dividend payable in Shares or by a split up of Shares or other similar event, then,
on the effective day thereof, the number of Shares purchasable hereunder shall be increased in proportion to such increase in
outstanding Shares, and the Exercise Price shall be proportionately decreased.

 

4.1.2.
Aggregation of Shares. If, after the date hereof, and subject to the provisions of Section 5.3 below, the number
of outstanding Shares is decreased by a consolidation, combination or reclassification of Shares or other similar event, then,
on the effective date thereof, the number of Shares purchasable hereunder shall be decreased in proportion to such decrease in
outstanding Shares, and the Exercise Price shall be proportionately increased.

 

     3

     

    

 

4.1.3.
Replacement of Securities Upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding
Shares other than a change covered by Section 5.1.1 or Section 5.1.2 hereof or that solely affects the par value
of such Shares, or in the case of any share reconstruction or amalgamation or consolidation of the Company with or into another
corporation (other than a consolidation or share reconstruction or amalgamation in which the Company is the continuing corporation
and that does not result in any reclassification or reorganization of the outstanding Shares), or in the case of any sale or conveyance
to another corporation or entity of the property of the Company as an entirety or substantially as an entirety in connection with
which the Company is dissolved, this Purchase Warrant shall, immediately after such reorganization, reclassification, consolidation,
merger, sale or similar transaction, remain outstanding and shall thereafter, in lieu of or in addition to (as the case may be)
the number of Shares then exercisable under this Purchase Warrant, be exercisable for the kind and number of shares of stock or
other securities or assets of the Company or of the successor person resulting from such transaction to which the Holder would
have been entitled upon such reorganization, reclassification, consolidation, merger, sale or similar transaction if the Holder
had exercised this Warrant in full immediately prior to the time of such reorganization, reclassification, consolidation, merger,
sale or similar transaction and acquired the applicable number of Shares then issuable hereunder as a result of such exercise
(without taking into account any limitations or restrictions on the exercisability of this Purchase Warrant); and, in such case,
appropriate adjustment shall be made with respect to the Holder’s rights under this Purchase Warrant to insure that the
provisions of this Section 5.1.3 hereof shall thereafter be applicable, as nearly as possible, to this Purchase Warrant
in relation to any shares of stock, securities or assets thereafter acquirable upon exercise of this Purchase Warrant (including,
in the case of any consolidation, merger, sale or similar transaction in which the successor or purchasing person is other than
the Company, an immediate adjustment in the Exercise Price to the value per share reflected by the terms of such consolidation,
merger, sale or similar transaction, and a corresponding immediate adjustment to the number of Shares acquirable upon exercise
of this Purchase Warrant without regard to any limitations or restrictions on exercise, if the value so reflected is less than
the Exercise Price in effect immediately prior to such consolidation, merger, sale or similar transaction). The provisions of
this Section 4.1.3 shall similarly apply to successive reorganizations, reclassifications, consolidations, mergers, sales
or similar transactions. The Company shall not affect any such reorganization, reclassification, consolidation, merger, sale or
similar transaction unless, prior to the consummation thereof, the successor person (if other than the Company) resulting from
such reorganization, reclassification, consolidation, merger, sale or similar transaction, shall assume, by written instrument
substantially similar in form and substance to this Purchase Warrant and satisfactory to the Holder, the obligation to deliver
to the Holder such shares of stock, securities or assets which, in accordance with the foregoing provisions, such Holder shall
be entitled to receive upon exercise of this Warrant.

 

4.1.4.
Changes in Form of Purchase Warrant. This form of Purchase Warrant need not be changed because of any change pursuant to
this Section 4.1, and Purchase Warrants issued after such change may state the same Exercise Price and the same number
of Shares as are stated in the Purchase Warrants initially issued pursuant to this Agreement. The acceptance by any Holder of
the issuance of new Purchase Warrants reflecting a required or permissive change shall not be deemed to waive any rights to an
adjustment occurring after the Commencement Date or the computation thereof.

 

4.2.
Substitute Purchase Warrant. In case of any consolidation of the Company with, or share reconstruction or amalgamation
of the Company with or into, another corporation (other than a consolidation or share reconstruction or amalgamation which does
not result in any reclassification or change of the outstanding Shares), the corporation formed by such consolidation or share
reconstruction or amalgamation shall execute and deliver to the Holder a supplemental Purchase Warrant providing that the holder
of each Purchase Warrant then outstanding or to be outstanding shall have the right thereafter (until the stated expiration of
such Purchase Warrant) to receive, upon exercise of such Purchase Warrant, the kind and amount of shares and other securities
and property receivable upon such consolidation or share reconstruction or amalgamation, by a holder of the number of Shares of
the Company for which such Purchase Warrant might have been exercised immediately prior to such consolidation, share reconstruction
or amalgamation, sale or transfer. Such supplemental Purchase Warrant shall provide for adjustments which shall be identical to
the adjustments provided for in this Section 5. The above provision of this Section shall similarly apply to successive
consolidations or share reconstructions or amalgamations.

 

     4

     

    

 

4.3.
Elimination of Fractional Interests. The Company shall not be required to issue certificates representing fractions of
Shares upon the exercise of the Purchase Warrant, nor shall it be required to issue scrip or pay cash in lieu of any fractional
interests, it being the intent of the parties that all fractional interests shall be eliminated by rounding any fraction up or
down, as the case may be, to the nearest whole number of Shares or other securities, properties or rights.

 

5.
Reservation and Listing.

 

5.1.
The Company shall at all times reserve and keep available out of its authorized Shares, solely for the purpose of issuance upon
exercise of the Purchase Warrants, such number of Shares or other securities, properties or rights as shall be issuable upon the
exercise thereof. The Company covenants and agrees that, upon exercise of the Purchase Warrants and payment of the Exercise Price
therefor, in accordance with the terms hereby, all Shares and other securities issuable upon such exercise shall be duly and validly
issued, fully paid and non-assessable, free from all taxes, liens and charges in respect of the issue thereof (other than taxes
in respect of any transfer occurring contemporaneously with such issue) and not subject to preemptive rights of any shareholder.
As long as the Purchase Warrants shall be outstanding, the Company shall use its best efforts to cause all Shares issuable upon
exercise of the Purchase Warrants to be listed (subject to official notice of issuance) on all national securities exchanges (or,
if applicable, quoted on the OTC Bulletin Board or any successor trading market) on which the Company’s shares of common
stock may then be listed and/or quoted.

 

5.2.
Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation,
amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution,
issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the
terms of this Purchase Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking
of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Purchase Warrant against
impairment. Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Shares above
the amount payable therefor upon the exercise of this Purchase Warrant, (ii) take all such action as may be necessary or appropriate
in order that the Company may validly and legally issue fully paid and nonassessable Shares upon the exercise of this Purchase
Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public
regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this
Purchase Warrant.

 

5.3.
Before taking any action which would result in an adjustment in the number of Shares for which this Purchase Warrant is exercisable
or in the Exercise Price, the Company shall obtain all such authorizations therefor, exemptions thereof, or consents thereto,
as may be necessary from any regulatory body having jurisdiction thereof

 

6.
Certain Notice Requirements.

 

6.1.
Holder’s Right to Receive Notice. Nothing herein shall be construed as conferring upon the Holders the right to vote
or consent or to receive notice as a shareholder for the election of directors or any other matter, or as having any rights whatsoever
as a shareholder of the Company. If, however, at any time prior to the expiration of the Purchase Warrants and their exercise,
any of the events described in Section 6.2 shall occur, then, in one or more of said events, the Company shall give written
notice of such event at least ten (10) days prior to the date fixed as a record date or the date of closing the transfer books
for the determination of the shareholders entitled to such dividend, distribution, conversion or exchange of securities or subscription
rights, or entitled to vote on such proposed dissolution, liquidation, winding up or sale. Such notice shall specify such record
date or the date of the closing of the transfer books, as the case may be. Notwithstanding the foregoing, the Company shall deliver
to each Holder a copy of each notice given to the other shareholders of the Company at the same time and in the same manner that
such notice is given to the shareholders.

 

     5

     

    

 

6.2.
Events Requiring Notice. The Company shall be required to give the notice described in this Section 6 upon one or
more of the following events: (i) if the Company shall take a record of the holders of its Shares for the purpose of entitling
them to receive a dividend or distribution payable otherwise than in cash, or a cash dividend or distribution payable otherwise
than out of retained earnings, as indicated by the accounting treatment of such dividend or distribution on the books of the Company,
(ii) the Company shall offer to all the holders of its Shares any additional shares of capital stock of the Company or securities
convertible into or exchangeable for shares of capital stock of the Company, or any option, right or warrant to subscribe therefor,
or (iii) a dissolution, liquidation or winding up of the Company (other than in connection with a consolidation or share reconstruction
or amalgamation) or a sale of all or substantially all of its property, assets and business shall be proposed.

 

6.3.
Notice of Change in Exercise Price. The Company shall, promptly after an event requiring a change in the Exercise Price
pursuant to Section 4 hereof, send notice to the Holders of such event and change (“Price Notice”).
The Price Notice shall describe the event causing the change and the method of calculating same and shall be certified as being
true and accurate by the Company’s Chief Financial Officer.

 

6.4.
Transmittal of Notices. All notices, requests, consents and other communications under this Purchase Warrant shall be in
writing and shall be deemed to have been duly made when hand delivered, or mailed by express mail or private courier service:
(i) if to the registered Holder of the Purchase Warrant, to the address of such Holder as shown on the books of the Company, or
(ii) if to the Company, to following address or to such other address as the Company may designate by notice to the Holders:

 

American
BriVision (Holding) Corporation

44370
Old Warm Springs Blvd.

Fremont,
CA 94538

Attn:
Howard Doong, CEO

Fax
No.: [●]

 

With
a copy (which shall not constitute notice) to:

 

Hunter
Taubman Fischer & Li LLC

1450
Broadway, 26 FL

New
York, NY10018

Attn:
Joan Wu, Esq.

Fax
No.: (212) 202-6380

 

6.5.
Amendments. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company
and the Holder.

 

6.6.
Headings. The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way
limit or affect the meaning or interpretation of any of the terms or provisions of this Purchase Warrant.

 

6.7.
Entire Agreement. This Purchase Warrant (together with the other agreements and documents being delivered pursuant to or
in connection with this Purchase Warrant) constitutes the entire agreement of the parties hereto with respect to the subject matter
hereof, and supersedes all prior agreements and understandings of the parties, oral and written, with respect to the subject matter
hereof.

 

     6

     

    

 

6.8.
Limitation of Liability. No provision hereof, in the absence of affirmative action by the Holder sufficient to exercise
this Purchase Warrant to purchase Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise
to any liability of the Holder for the purchase price of any shares of common stock or as a stockholder of the Company, whether
such liability is asserted by the Company or by creditors of the Company.

 

6.9.
Severability. Wherever possible, each provision of this Purchase Warrant shall be interpreted in such manner as to be effective
and valid under applicable law, but if any provision of this Purchase Warrant shall be prohibited by or invalid under applicable
law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of
such provision or the remaining provisions of this Purchase Warrant.

 

6.10.
Binding Effect. This Purchase Warrant shall inure solely to the benefit of and shall be binding upon, the Holder and the
Company and their permitted assignees, respective successors, legal representative and assigns, and no other person shall have
or be construed to have any legal or equitable right, remedy or claim under or in respect of or by virtue of this Purchase Warrant
or any provisions herein contained.

 

6.11.
Governing Law; Submission to Jurisdiction; Trial by Jury. This Purchase Warrant shall be governed by and construed and
enforced in accordance with the laws of the State of New York, without giving effect to conflict of laws principles thereof. Each
of the Company and the Holder hereby agrees that any action, proceeding or claim against it arising out of, or relating in any
way to this Purchase Warrant shall be brought and enforced in the New York Supreme Court, County of New York, or in the United
States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction
shall be exclusive. Each of the Company and the Holder hereby waives any objection to such exclusive jurisdiction and that such
courts represent an inconvenient forum. Any process or summons to be served upon the Company or the Holder may be served by transmitting
a copy thereof by registered or certified mail, return receipt requested, postage prepaid, addressed to it at the address set
forth in Section 8 hereof. Such mailing shall be deemed personal service and shall be legal and binding upon the Company and the
Holder in any action, proceeding or claim. The Company and the Holder agree that the prevailing party(ies) in any such action
shall be entitled to recover from the other party(ies) all of its reasonable attorneys’ fees and expenses relating to such
action or proceeding and/or incurred in connection with the preparation therefor. The Company (on its behalf and, to the extent
permitted by applicable law, on behalf of its shareholders and affiliates) and the Holder hereby irrevocably waive, to the fullest
extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this
Agreement or the transactions contemplated hereby.

 

6.12.
Waiver, etc. The failure of the Company or the Holder to at any time enforce any of the provisions of this Purchase Warrant
shall not be deemed or construed to be a waiver of any such provision, nor to in any way affect the validity of this Purchase
Warrant or any provision hereof or the right of the Company or any Holder to thereafter enforce each and every provision of this
Purchase Warrant. No waiver of any breach, non-compliance or non-fulfillment of any of the provisions of this Purchase Warrant
shall be effective unless set forth in a written instrument executed by the party or parties against whom or which enforcement
of such waiver is sought; and no waiver of any such breach, non-compliance or non-fulfillment shall be construed or deemed to
be a waiver of any other or subsequent breach, non-compliance or non-fulfillment. Without limiting any other provision of this
Purchase Warrant or the Agreement, if the Company willfully and knowingly fails to comply with any provision of this Purchase
Warrant, which results in any damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to
cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings,
incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies
hereunder.

 

[Signature
Page Follows]

 

     7

     

    

 

IN
WITNESS WHEREOF, the Company has caused this Purchase Warrant to be signed by its duly authorized officer as of the [●]
day of [●], 2020.

 

	American
    BriVision (Holding) Corporation	 
	 	 
	By:	 	 
	 	 
		Name:Chihliang An	 
		Title:Chief Financial Officer	 

 

     

     

    

 

[FORM
TO BE USED TO EXERCISE PURCHASE WARRANT]

 

Date: ________________

 

The
undersigned hereby elects irrevocably to exercise the Purchase Warrant for [●] shares of common stock, par value $0.001
(the “Shares”), of American BriVision (Holding) Corporation, a Nevada company (the “Company”),
and hereby makes payment of $ [●] (at the rate of $[●] per Share) in payment of the Exercise Price pursuant thereto.
Please issue the Shares as to which this Purchase Warrant is exercised in accordance with the instructions given below and, if
applicable, a new Purchase Warrant representing the number of Shares for which this Purchase Warrant has not been exercised.

 

Please
issue the Shares as to which this Purchase Warrant is exercised in accordance with the instructions given below and, if applicable,
a new Purchase Warrant representing the number of Shares for which this Purchase Warrant has not been converted.

 

	Signature	 	 

 

	Signature Guaranteed	 	 

 

INSTRUCTIONS
FOR REGISTRATION OF SECURITIES

 

	Name: 	 	 
	 	(Print in Block Letters)	 
	 	 	 
	Address:	 	 
	 	 	 
	 	 	 
	 	 	 

 

NOTICE:
The signature to this form must correspond with the name as written upon the face of the Purchase Warrant without alteration or
enlargement or any change whatsoever, and must be guaranteed by a bank, other than a savings bank, or by a trust company or by
a firm having membership on a registered national securities exchange.

 

     

     

    

 

[FORM
TO BE USED TO ASSIGN PURCHASE WARRANT]

 

ASSIGNMENT

 

(To
be executed by the registered Holder to effect a transfer of the within Purchase Warrant):

 

FOR
VALUE RECEIVED, [●] does hereby sell, assign and transfer unto the right to purchase shares of common stock, par value $0.001,
of American BriVision (Holding) Corporation, a Nevada company (the “Company”), evidenced by the Purchase Warrant
and does hereby authorize the Company to transfer such right on the books of the Company.

 

	Dated	 	 
	 	 
	Signature	 	 

 

	Signature Guaranteed	 	 

 

NOTICE:
The signature to this form must correspond with the name as written upon the face of the within Purchase Warrant without alteration
or enlargement or any change whatsoever, and must be guaranteed by a bank, other than a savings bank, or by a trust company or
by a firm having membership on a registered national securities exchange.Exhibit 10.1

EXCHANGE AGREEMENT

 

THIS EXCHANGE AGREEMENT
(the “Agreement”) is made as of April 20, 2020 (the “Effective Date”), by and between American
BriVision (Holding) Corporation, a Nevada corporation (the “Company”) and the undersigned hereof (the “Investor”).

 

WHEREAS, pursuant
to certain Securities Purchase Agreements dated [●] (the “SPA”), the Company issued to the Investor certain
convertible promissory note for the aggregate principal amount of $[●] plus accrued interest expenses (the “Original
Note”);

 

WHEREAS, subject
to the satisfaction of the conditions set forth herein, the Company and the Investor desire to enter into a transaction (the “Exchange”)
wherein, in exchange of the Original Note, the Company shall issue to the Investor such number of shares (“Shares”)
of common stock, par value $0.001, of the Company set forth on the signature page hereof, and the Warrant (the “Warrant”)
to purchase such number shares of common stock set forth on the signature page hereof (the “Warrant Shares”)
at an initial exercise price of $5.00 per share exercisable three years after the issuance date, in the form attached hereto as
Exhibit A, the Warrant and the Shares are collectively referred to as the “Securities”).

 

NOW, THEREFORE,
for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

 

1. Exchange; Forbearance.
The closing (the “Closing”) of the Exchange will occur on or before third Trading Day (or such later date as
the parties hereto may agree in writing) following the satisfaction or waiver of the conditions set forth herein (such date, the
“Closing Date”). From the date of this Agreement up to and through 5:00 pm Eastern Standard time on the Closing
Date, the Investor shall take no action to enforce its rights under the Original Note. On the Closing Date, subject to the terms
and conditions of this Agreement, the Investor and the Company shall exchange the Original Note for the Securities. At the Closing,
the following transactions shall occur:

 

1.1. On the Closing Date,
the Company shall issue the Shares and deliver the Warrant to the Investor. On the Closing Date, the Investor shall be deemed for
all purposes to have become the holder of record of the Shares and the Warrant, irrespective of the date the Company delivers the
Shares and Warrant to the Investor.

 

1.2. Upon receipt of
the Shares and Warrant in accordance with this Section 1.1, all of the Investor’s rights under the Original Note shall be
extinguished. Within three Trading Days of the Closing, the investor shall deliver the Original Note to the Company for cancellation.

 

1.3 It shall be a condition
to the obligation of the Investor, on the one hand, and the Company, on the other hand, to consummate the Exchange contemplated
hereunder that the other party’s representations and warranties contained herein are true and correct on the Closing Date
with the same effect as though made on such date, unless waived in writing by the party to whom such representations and warranties
are made.

 

     

     

    

 

2. Representations
and Warranties of the Company. The Company hereby represents and warrants to the Investor that:

 

2.1 Organization.
The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Nevada, with
the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted.
The Company is not in violation nor default of any of the provisions of its certificate of incorporation, bylaws or other organizational
or charter documents. The Company is duly qualified to conduct business and is in good standing as a foreign corporation or other
entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary,
and no claim, action or proceeding of any kind has been instituted in any such jurisdiction revoking, limiting or curtailing or
seeking to revoke, limit or curtail such power and authority or qualification.

 

2.2 Authorization.
This Agreement has been duly and validly authorized, executed and delivered on behalf of the Company and shall constitute the legal,
valid and binding obligations of the Company enforceable against the Company in accordance with their respective terms, except
as such enforceability may be limited by general principles of equity or to applicable bankruptcy, insolvency, reorganization,
moratorium, liquidation and other similar laws relating to, or affecting generally, the enforcement of applicable creditors’
rights and remedies. The execution, delivery and performance by the Company of this Agreement and the consummation by the Company
of the transactions contemplated hereby and thereby will not: (i) conflict with, or constitute a default (or an event which with
notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration
or cancellation of, any agreement, indenture or instrument to which the Company is a party or by which it is bound; or (ii) result
in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities or “blue sky”
laws) applicable to the Company, provided Exchange Approval (as hereinafter defined) is obtained in a timely manner.

 

2.3 Valid Issuance
of the Shares and Warrant. The Shares and the Warrant when issued and delivered in accordance with the terms of this Agreement,
for the consideration expressed herein, and the Warrant Shares when issued in accordance with the terms of the Warrant, will be
duly and validly issued, fully paid and non-assessable, free and clear of all Liens imposed by the Company other than restrictions
on transfer provided for in the Transaction Documents.

 

2.4 Compliance With
Laws. The Company has complied in all material respects with all laws, rules, and regulations applicable to it and its business,
and the Company has not received notice of any such violation.

 

2.5 Consents; Waivers.
No consent, waiver, approval or authority of any nature, or other formal action, by any person or entity, not already obtained,
other than Exchange Approval, is required in connection with the execution and delivery of this Agreement by the Company or the
consummation by the Company of the transactions provided for herein and therein.

 

2.6 Acknowledgment
Regarding Investor’s Purchase of the Shares. The Company acknowledges and agrees that the Investor is acting solely in
the capacity of arm’s length Investor with respect to this Agreement and the Exchange and the transactions contemplated hereby
and thereby and that the Investor is not: (i) an officer or director of the Company; (ii) an “affiliate” of the Company
(as defined in Rule 144 promulgated under the Securities Act); or (iii) to the knowledge of the Company, a “beneficial owner”
of 4.99% or more of the shares of Common Stock (as defined for purposes of Rule 13d-3 under the Securities Exchange Act of 1934
(the “Exchange Act”). The Company further acknowledges that the Investor is not acting as a financial advisor
or fiduciary of the Company (or in any similar capacity) with respect to the Exchange, this Agreement, any other document or agreement
delivered in connection herewith or therewith or the transactions contemplated hereby and thereby, and any advice given by the
Investor or any of its representatives or agents in connection with the Exchange, this Agreement, any other document or agreement
delivered in connection herewith or therewith or the transactions contemplated hereby and thereby is merely incidental to the Investor’s
acceptance of the Shares. The Company further represents to the Investor that the Company’s decision to enter into the Exchange
has been based solely on the independent evaluation by the Company and its representatives.

 

    2

     

    

  

3. Representations
and Warranties of the Investor. The Investor hereby represents, warrants and covenants that:

 

3.1. Authority.
The Investor has the full right and power to enter into and perform pursuant to this Agreement and to make an investment in the
Company, and this Agreement constitutes the Investor’s valid and legally binding obligation, enforceable in accordance with
its terms. The Investor is authorized and otherwise duly qualified to purchase and hold the Securities and to enter into this Agreement.

 

3.2. Authorization.
This Agreement has been duly and validly authorized, executed and delivered on behalf of the Investor and shall constitute the
legal, valid and binding obligations of the Investor enforceable against the Investor in accordance with their respective terms,
except as such enforceability may be limited by general principles of equity or to applicable bankruptcy, insolvency, reorganization,
moratorium, liquidation and other similar laws relating to, or affecting generally, the enforcement of applicable creditors’
rights and remedies. The execution, delivery and performance by the Investor of this Agreement and the consummation by the Investor
of the transactions contemplated hereby and thereby will not: (i) conflict with, or constitute a default (or an event which with
notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration
or cancellation of, any agreement, indenture or instrument to which the Investor is a party or by which it is bound; or (ii) result
in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities or “blue sky”
laws) applicable to the Investor.

 

3.3.Regulation S Exemption,
Non U.S Person. The Investor understands that the Securities are being offered and sold to it in reliance on an exemption
from the registration requirements of the United States federal and state securities laws under Regulation S promulgated under
the Securities Act and that the Company is relying upon the truth and accuracy of the representations, warranties, agreements,
acknowledgments and understandings of the Investor set forth herein in order to determine the applicability of such exemptions
and the suitability of the Investor to acquire the Securities. In this regard, the Investor represents, warrants and agrees that:

 

(1) No Investor is a
U.S. Person (as defined below). Status of Investor. The Investor is a “non-US person” as defined in Regulation S. The
Investor further makes the representations and warranties to the Company set forth on Exhibit A. Such Investor is not required
to be registered as a broker-dealer under Section 15 of the Exchange Act and such Investor is not a broker-dealer, nor an affiliate
of a broker-dealer.

 

(2) At the time of the
origination of contact concerning this Agreement and the date of the execution and delivery of this Agreement, the Investor was
outside of the United States.

 

(3) The Investor will
not, during the period commencing on the date of issuance of the Securities and ending on the end of the sixth month of such date,
or such shorter period as may be permitted by Regulation S or other applicable securities law (“Restricted Period”),
offer, sell, pledge or otherwise transfer the Securities in the United States, or to a U.S. Person for the account or benefit of
a U.S. Person, or otherwise in a manner that is not in compliance with Regulation S.

 

(4) The Investor will,
after expiration of the Restricted Period, offer, sell, pledge or otherwise transfer the Securities only pursuant to registration
under the Securities Act or an available exemption therefrom and, in accordance with all applicable state and foreign securities
laws.

 

(5) The Investor has
not in the United States, engaged in, and prior to the expiration of the Restricted Period will not engage in, any short selling
of or any hedging transaction with respect to the Securities, including without limitation, any put, call or other option transaction,
option writing or equity swap.

 

    3

     

    

 

(6) Neither the Investor
nor any person acting on the Investor’s behalf has engaged, nor will engage, in any directed selling efforts to U.S. Persons
with respect to the Securities and the Investor and any person acting on its behalf have complied and will comply with the “offering
restrictions” requirements of Regulation S under the Securities Act.

 

(7) The transactions
contemplated by this Agreement have not been pre-arranged with a buyer located in the United States or with a U.S. Person, and
are not part of a plan or scheme to evade the registration requirements of the Securities Act.

 

(8) Neither any Investor
nor any person acting on the Investor’s behalf has undertaken or carried out any activity for the purpose of, or that could
reasonably be expected to have the effect of, conditioning the market in the United States, its territories or possessions, for
any of the Securities. The Investor agrees not to cause any advertisement of the Securities to be published in any newspaper or
periodical or posted in any public place and not to issue any circular relating to the Securities, except such advertisements that
include the statements required by Regulation S under the Securities Act, and only offshore and not in the U.S. or its territories,
and only in compliance with any local applicable securities laws.

 

(9) The Investor has
engaged in any “Directed Selling Efforts in the U.S.”, as defined in Regulation S promulgated by the U.S. Securities
and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”).

 

(10) The Investor
acquires the Securities solely for its own account for the purpose of investment and not with a view to or for sale in connection
with a distribution to anyone. The Investor has no present plan or intention to sell the Securities in the United States or to
a U.S. person at any predetermined time, has made no predetermined arrangements to sell the Securities and is not acting as a distributor
of such securities.

 

3.4. No Governmental
Review. The Investor understands that no United States federal or state agency or any other government or governmental agency
has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment in the
Securities nor have such authorities passed upon or endorsed the merits of the offering of the Securities.

 

3.5. Ownership of
Original Note. The Investor owns and holds, beneficially and of record, the entire right, title, and interest in and to the
Original Note free and clear of all rights and Liens (other than pledges or security interests (x) arising by operation of applicable
securities laws and (y) that the Investor may have created in favor of a prime broker under and in accordance with its prime brokerage
agreement with such broker). The Investor has full power and authority to transfer and dispose of the Original Note to the Company
free and clear of any right or lien. Other than the transactions contemplated by this Agreement, there is no outstanding, plan,
pending proposal, or other right of any person or entity to acquire all or any part of the Original Note or any Securities of Common
Stock issuable upon the delivery of the Issuance Notice and corresponding deduction of the face amount of the Securities, or pursuant
to the terms of the Warrant.

 

3.6. Sophistication
and Knowledge. The Investor and/or with its representative(s) has such knowledge and experience in financial and business matters
that it can represent itself and is capable of evaluating the merits and risks of the purchase of the Securities. The Investor
is not relying on the Company with respect to the tax and other economic considerations of an investment in the Securities, and
the Investor has relied on the advice of, or has consulted with, only the Investor’s own advisor(s).

 

    4

     

    

  

3.7 Investment Experience.
Such Investor acknowledges that the investment in the Securities pursuant to this Agreement is a highly speculative investment
and that it can bear the economic risk and complete loss of such investment and has such knowledge and experience in financial
or business matters such that it is capable of evaluating the merits and risks of the investment contemplated hereby. The Investor
is not relying on the Company with respect to the tax and other economic considerations of an investment in the Securities, and
the Investor has relied on the advice of, or has consulted with, only the Investor’s own advisor(s).

 

3.8 Access to Information.
The Investor, in making the decision to purchase the Securities, has relied solely upon independent investigations made by it and/or
its representatives, if any. The Investor and/or its representatives during the course of this transaction, and prior to the purchase
of any Securities, has had the opportunity to ask questions of and receive answers from the management of the Company concerning
the terms and conditions of the offering of the Securities and to receive any additional information, documents, records and books
relative to its business, assets, financial condition, results of operations and liabilities (contingent or otherwise) of the Company.
The Investor acknowledges that it understands that the Company publishes periodic reports under the Securities Exchange Act of
1934 on the website of the Securities and Exchange Commission (the “SEC”), which can be accessed at www.sec.gov. Such
Investor has read the Company’s periodic reports available online and acknowledges that such information is sufficient for
the Investor to evaluate the risks of investing in the Securities. The Investor is not relying on any disclosures concerning the
Company made by the Company or any officer, employee or agent of the Company, other than those contained in the public reports
filed by the Company with the SEC.

 

3.9 Lack of Liquidity.
The Investor acknowledges that the purchase of the Securities involves a high degree of risk and further acknowledges that it can
bear the economic risk of the purchase of the Securities, including the total loss of its investment. The Investor has no present
need for liquidity in connection with its purchase of the Securities.

 

3.10 No Public Solicitation.
The Investor is not subscribing for the Securities as a result of or subsequent to any advertisement, article, notice or other
communication published in any newspaper, magazine or similar media or broadcast over television or radio, or presented at any
seminar or meeting, or any solicitation of a subscription by a person not previously known to the Investor in connection with investments
in securities generally.

 

3.11 Restricted Securities.

 

(1) The Investor understands
that the Securities have not been registered under the Securities Act, by reason of a specific exemption from the registration
provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment intent and the
accuracy of the Investor’s representations as expressed herein. The Investor understands that the Securities are “restricted
securities” under applicable U.S. federal and state securities laws and that, pursuant to these laws, the Investor must hold
the Securities indefinitely unless they are registered with the SEC and qualified by state authorities, or an exemption from such
registration and qualification requirements is available. The Investor acknowledges that the Company has no obligation to register
or qualify the Securities for resale. The Investor further acknowledges that if an exemption from registration or qualification
is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding
period for the Securities, and on requirements relating to the Company which are outside of the Investor’s control, and which
the Company is under no obligation and may not be able to satisfy. The Investor understands that this offering is not intended
to be part of the public offering, and that the Investor will not be able to rely on the protection of Section 11 of the Securities
Act.

 

    5

     

    

  

(2) Such
Investor acknowledges that such Investor is familiar with Rule 144 and Rule 144A, of the rules and regulations of the Commission,
as amended, promulgated pursuant to the Securities Act (“Rule 144”), and that such person has been advised that
Rule 144 and Rule 144A, as applicable, permits resales only under certain circumstances. Such Investor understands that to the
extent that Rule 144 or Rule 144A is not available, such Investor will be unable to sell any Securities without either registration
under the Securities Act or the existence of another exemption from such registration requirement.

 

(3) Each certificate
representing the Securities and the Warrant shall be endorsed with the following legends as well as any other legend required to
be placed thereon by applicable federal or state securities laws.:

 

“THE SECURITIES
ARE BEING OFFERED TO INVESTORS WHO ARE NOT U.S. PERSONS (AS DEFINED IN REGULATION S UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(“THE SECURITIES ACT”)) AND WITHOUT REGISTRATION WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION UNDER THE
SECURITIES ACT IN RELIANCE UPON REGULATION S PROMULGATED UNDER THE SECURITIES ACT. “

 

“TRANSFER OF THESE
SECURITIES IS PROHIBITED, EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S, PURSUANT TO REGISTRATION UNDER THE SECURITIES
ACT, OR PURSUANT TO AVAILABLE EXEMPTION FROM REGISTRATION. HEDGING TRANSACTIONS MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH
THE SECURITIES ACT. “

 

(4) The Investor consents
to the Company making a notation on its records or giving instructions to any transfer agent of the Company in order to implement
the restrictions on transfer of the Securities.

 

54. Additional Covenants

 

4.1. Blue Sky.
The Company shall make all filings relating to the Exchange required by Regulation D under the Securities Act and under applicable
securities or “blue sky” laws of the states of the United States following the date hereof.

 

4.2. Fees and Expenses.
Except as otherwise set forth in this Agreement, each party to this Agreement shall pay the fees and expenses of its advisers,
counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation,
execution, delivery and performance of this Agreement. Notwithstanding the foregoing, the Company will reimburse the Investor for
$10,000 in legal expenses upon execution of this Agreement.

 

5. Miscellaneous

 

5.1. Successors and
Assigns. Except as otherwise provided herein, the terms and conditions of this Agreement shall inure to the benefit of and
be binding upon the parties hereto and the respective successors and assigns of the parties. Nothing in this Agreement, express
or implied, is intended to confer upon any party, other than the parties hereto or their respective successors and assigns, any
rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.

 

    6

     

    

  

5.2. Governing Law;
Exclusive Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Agreement
shall be governed by the internal laws of the Commonwealth of Pennsylvania, without giving effect to any choice of law or conflict
of law provision or rule (whether of the Commonwealth of Pennsylvania or any other jurisdictions) that would cause the application
of the laws of any jurisdictions other than the Commonwealth of Pennsylvania. Each party hereby irrevocably submits to the exclusive
jurisdiction of the state or federal courts sitting in or for Delaware County, Pennsylvania, for the adjudication of any dispute
hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives,
and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action
or proceeding is improper. Each of the parties hereby waives any objection to such exclusive jurisdiction and that such courts
represent an inconvenient forum.

 

5.3. Notices.
All notices, offers, acceptance and any other acts under this Agreement (except payment) shall be in writing, and shall be sufficiently
given if delivered to the addressees in person, by FedEx or similar overnight next Trading Day delivery, or by email followed by
overnight next Trading Day delivery, to the address as provided for on the signature page to this agreement.

 

5.4. Amendments and
Waivers. Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally
or in a particular instance and either retroactively or prospectively), only with the written consent of the Company and the Investor.

 

5.5. Severability.
If one or more provisions of this Agreement are held to be unenforceable under applicable law, such provision shall be excluded
from this Agreement and the balance of the Agreement shall be interpreted as if such provision were so excluded and shall be enforceable
in accordance with its terms so long as this Agreement as so modified continues to express, without material change, the original
intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s)
in question does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical
realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations
to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close
as possible to that of the prohibited, invalid or unenforceable provision(s).

 

5.6. Counterparts.
This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together
shall constitute one and the same instrument.

 

5.7. Survival.
The representations, warranties and covenants of the Company and the Investor contained herein shall survive the Closing and delivery
of the Shares.

 

6. Definitions.
For purposes of this Agreement, the following words and terms shall have the following meanings:

 

6.1 “Liens”
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.

 

    7

     

    

 

6.2. “Person”
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity or a government or any department or agency thereof.

  

6.3. “Principal
Market” means any of The New York Stock Exchange, the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Select
Market, the Nasdaq Global Market, the OTCQB, the OTCQX, the OTC Pink or any other market operated by the OTC Markets Group Inc.
or any successors of any of these exchanges or markets.

 

6.4. “Trading
Day” means, as applicable, (x) with respect to all price or trading volume determinations relating to the Common Stock,
any day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the principal trading market
for the Common Stock, then on the principal securities exchange or securities market on which the Common Stock is then traded,
provided that “Trading Day” shall not include any day on which the Common Stock is scheduled to trade on such exchange
or market for less than 4.5 hours or any day that the Common Stock is suspended from trading during the final hour of trading on
such exchange or market (or if such exchange or market does not designate in advance the closing time of trading on such exchange
or market, then during the hour ending at 4:00 p.m., New York time) unless such day is otherwise designated as a Trading Day in
writing by the Investor or (y) with respect to all determinations other than price determinations relating to the Common Stock,
any day on which The New York Stock Exchange (or any successor thereto) is open for trading of securities.

 

6.5. “Transaction
Documents” means this Agreement, the Shares and all exhibits and schedules thereto and hereto and any other documents
or agreements executed in connection with the transactions contemplated hereunder.

 

[SIGNATURES ON THE FOLLOWING PAGE]

  

    8

     

    

   

IN WITNESS WHEREOF, the parties
have caused this Agreement to be duly executed and delivered as of the date provided above.

 

	 	COMPANY:
	 	 
	 	American BriVision (Holding) Corporation 
	 	 
	 	By: 	/s/ Chihliang An
	 	 	Name: Chihliang An 
	 	 	Title: Chief Financial Officer 
	 	 
	 	Address for Notices: 
	 	 
	 	44370 Old Warm Springs Blvd.
	 	Fremont, CA 94538

 

     

     

    

  

IN WITNESS WHEREOF, the parties have caused
this Agreement to be duly executed and delivered as of the date provided above.

 

	 	INVESTOR: 
	 	 
	 	[●]
	 	 
	 	By: 	                            
	 	 	Name: [●]
	 	 	Title: [●]
	 	 
	 	
        Principal Amount of the Original Note: __________

         

        Number of Shares of Common Stock to be received:____________1

         

        Warrant to Purchase such number of share of Commons Stock: __________
        2

	 	
          

        Address for Notices:

	 	 
	 	 
	 	 
	 	 

 

 

1 The number
of Shares shall be the principal amount of the Original Note divided by 70% of the average OTC closing price for the 15 trading
days preceding the Closing of the Exchange.

 

2 The number
of Warrant Shares shall be the principal amount of the Original Note divided by 70% of the average OTC closing price for the 15
trading days preceding the Closing of the Exchange.

 

     

     

    

 

EXHIBT A

 

Form of Warrant

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00308-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00308-of-00352.parquet"}]]